![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 309/10 | |
A61K 31/351 | |||
A61P 3/10 |
(11) | Number of the document | 3466939 |
(13) | Kind of document | T |
(96) | European patent application number | 17802110.1 |
Date of filing the European patent application | 2017-05-22 | |
(97) | Date of publication of the European application | 2019-04-10 |
(45) | Date of publication and mention of the grant of the patent | 2021-02-24 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2017/085295 |
Date | 2017-05-22 |
(87) | Number | WO 2017/202264 |
Date | 2017-11-30 |
(30) | Number | Date | Country code |
201610347924 | 2016-05-24 | CN |
(72) |
LI, Xiang, CN
HE, Lei, CN
YU, Jun, CN
WANG, Jinjia, CN
DU, Zuyin, CN
|
(73) |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.,
Economic and Technological Development Zone Lianyungang, Jiangsu 222047,
CN
|
(54) | NEW DAPAGLIFLOZIN CRYSTAL FORM AND PREPARATION METHOD AND USE THEREOF |
NEW DAPAGLIFLOZIN CRYSTAL FORM AND PREPARATION METHOD AND USE THEREOF |